BlackRock’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-7,199,683
| Closed | -$24.5M | – | 5049 |
|
|
2018
Q3 | $24.5M | Buy |
7,199,683
+586,238
| +9% | +$1.99M | ﹤0.01% | 2735 |
|
|
2018
Q2 | $24.9M | Buy |
6,613,445
+534,831
| +9% | +$2.01M | ﹤0.01% | 2720 |
|
|
2018
Q1 | $24.9M | Sell |
6,078,614
-19,334
| -0.3% | -$79.1K | ﹤0.01% | 2632 |
|
|
2017
Q4 | $28.4M | Buy |
6,097,948
+112,381
| +2% | +$523K | ﹤0.01% | 2585 |
|
|
2017
Q3 | $42.5M | Buy |
5,985,567
+579,741
| +11% | +$4.12M | ﹤0.01% | 2358 |
|
|
2017
Q2 | $39.1M | Sell |
5,405,826
-9,505
| -0.2% | -$68.7K | ﹤0.01% | 2386 |
|
|
2017
Q1 | $33.4M | Buy |
5,415,331
+5,408,594
| +80,282% | +$33.3M | ﹤0.01% | 2441 |
|
|
2016
Q4 | $40K | Sell |
6,737
-1,246
| -16% | -$7.4K | ﹤0.01% | 2981 |
|
|
2016
Q3 | $42K | Hold |
7,983
| – | – | ﹤0.01% | 2992 |
|
|
2016
Q2 | $53K | Buy |
7,983
+1,860
| +30% | +$12.3K | ﹤0.01% | 2871 |
|
|
2016
Q1 | $28K | Buy |
6,123
+3,746
| +158% | +$17.1K | ﹤0.01% | 2626 |
|
|
2015
Q4 | $12K | Hold |
2,377
| – | – | ﹤0.01% | 2794 |
|
|
2015
Q3 | $8K | Hold |
2,377
| – | – | ﹤0.01% | 2830 |
|
|
2015
Q2 | $24K | Hold |
2,377
| – | – | ﹤0.01% | 2269 |
|
|
2015
Q1 | $30K | Hold |
2,377
| – | – | ﹤0.01% | 2139 |
|
|
2014
Q4 | $34K | Hold |
2,377
| – | – | ﹤0.01% | 2096 |
|
|
2014
Q3 | $33K | Hold |
2,377
| – | – | ﹤0.01% | 2073 |
|
|
2014
Q2 | $36K | Sell |
2,377
-655
| -22% | -$9.92K | ﹤0.01% | 2043 |
|
|
2014
Q1 | $51K | Buy |
3,032
+922
| +44% | +$15.5K | ﹤0.01% | 1892 |
|
|
2013
Q4 | $27K | Hold |
2,110
| – | – | ﹤0.01% | 2178 |
|
|
2013
Q3 | $21K | Hold |
2,110
| – | – | ﹤0.01% | 2248 |
|
|
2013
Q2 | $16K | Buy |
+2,110
| New | +$16K | ﹤0.01% | 2408 |
|